(Q48160662)

9 February 2018

title

The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formation (English)

1 reference

9 February 2018

Michel Jean Robert Perricaudet

main subject

endothelium

0 references

author

10

object named as

M Perricaudet

1 reference

9 February 2018

H Li

1

1 reference

9 February 2018

X Shi

2

1 reference

9 February 2018

J Liu

3

1 reference

9 February 2018

C Hu

4

1 reference

9 February 2018

X Zhang

5

1 reference

9 February 2018

H Liu

6

1 reference

9 February 2018

J Jin

7

1 reference

9 February 2018

P Opolon

8

1 reference

9 February 2018

J-P Vannier

9

1 reference

9 February 2018

A Janin

11

1 reference

9 February 2018

C Soria

12

1 reference

9 February 2018

H Lu

13

1 reference

9 February 2018

publication date

18 June 2010

1 reference

9 February 2018

published in

Cancer Gene Therapy

1 reference

9 February 2018

volume

17

1 reference

9 February 2018

issue

10

1 reference

9 February 2018

page(s)

700-707

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1038/cgt.2010.26

exact match

0 references

cites work

Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

The role of membrane-membrane interactions in the regulation of endothelial cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Tumor-suppressor gene products in cell contacts: the cadherin-APC-armadillo connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Endothelial cell-cell junctions: happy together

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

In vivo cell electrofusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Drug insight: vascular disrupting agents and angiogenesis--novel approaches for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Combination of antiangiogenesis with chemotherapy for more effective cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

A soluble truncated cadherin induces breast cancer cell apoptosis and growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

A role for cadherin-5 in regulation of vascular endothelial growth factor receptor 2 activity in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Endothelial cadherins and tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Catenin-dependent and -independent Functions of Vascular Endothelial Cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

inferred from DOI database lookup

7 January 2021

based on heuristic

AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

inferred from DOI database lookup

7 January 2021

based on heuristic

Downregulation of vascular endothelial-cadherin expression is associated with an increase in vascular tumor growth and hemorrhagic complications

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.26

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2010.26

1 reference

9 February 2018

1 reference

9 February 2018